medullary thyroid cancer semaglutide Tirzepatide and Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Adoptive T cell immunotherapy for

Large clinical trials, including those supporting FDA approval of semaglutide, show that gastrointestinal and appetite-related side effects are almost entirely reversible within weeks to months of stopping treatment

73(3): 85767 Gudjonsson H, Li B, Shug AL, et al

Cat owners may not recognize obesity or know about the associated health risks, which include diabetes mellitus, hepatic lipidosis, lameness, lower urinary tract disease, and other health problems

Additionally find out more on Biotech USA here.

Once hailed primarily for managing type 2 diabetes and chronic weight loss, these therapies are now reshaping cardiometabolic care with broader clinical impact and improved patient access